Allosteric modulators for
human health
About us
Addex Corporate Presentation
Overview
Our people
Executive Officers
Non-Executive Directors
Contact
Privacy Policy
Careers
Pipeline
Clinical and Pre-Clinical Pipeline
Research And Development
Technology
Allosteric modulation
Publications
Partners & collaboration
Investors
Addex Corporate Presentation
Stock Data
Press releases
Ad hoc announcements (Art. 53 L.R)
Events
Financial Reports
Analyst Reports
General Meetings
SEC / SIX Filings
Guide to US ADSS for Six Shareholders
Register for email news
Corporate Governance
Contact
Media
Press releases
Contact
Press releases
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Please select year
09.08
2010
Addex Awarded Michael J. Fox Foundation Grant for ADX48621 to Treat Levodopa-Induced Dyskinesia in Parkinson’s
09.02
2010
Addex Drug Candidate Effective in Alzheimer’s Disease Model
08.25
2010
Addex Partner Completes ADX71149 Phase I Program
07.28
2010
Addex Pharmaceuticals First Half 2010 Financial Results
07.21
2010
Addex First Half 2010 Financial Results Next Wednesday
07.13
2010
Addex Drug Candidate Effective in Osteoarthritis Pain Model
06.15
2010
Addex’s ADX48621 Effective in Preclinical Parkinson’s Disease Studies
05.18
2010
Addex Executive Management Change
05.11
2010
Addex R&D Day Highlights
04.30
2010
Addex Shareholders Approve All Board Proposals at 2010 AGM
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next
Back